FDA issues medtech appeals process guidance but will behaviour change at US agency?
This article was originally published in Clinica
Executive Summary
The US Food and Drug Administration has issued final guidance explaining the various mechanisms that are available to device companies to appeal against decisions made by the agency's Center for Devices and Radiological Health.